Green Earth Institute Co Ltd
Green Earth Institute maintains a strong liquidity position with cash and equivalents of ¥2,059.54 million, representing 69.4% of total assets. The company's debt-to-equity ratio of 0.07 indicates a conservative capital structure, with long-term debt accounting for just 6.9% of total equity. The current ratio of 3.34 suggests ample short-term liquidity to cover obligations. Profitability metrics show mixed performance. While the company reported a net income of ¥127.32 million, operating income was negative at ¥4.20 million, indicating operational inefficiencies. Return on equity of 6.05% and return on assets of 4.29% fall below the industry median for specialty chemicals, which typically exceeds 8% ROE and 5.5% ROA. The company's revenue is concentrated in two business models: research and development and license and product sales. Geographic exposure is primarily domestic, with no material international revenue disclosed in the latest annual report. This concentration increases vulnerability to domestic market fluctuations. Outlook for FY2024 shows a projected 12% revenue growth, driven by expanded licensing agreements and new product launches. However, operating income is expected to remain negative due to ongoing R&D investments. The company's free cash flow of ¥8.65 million is insufficient to cover capital expenditures of ¥150.99 million, signaling potential future liquidity pressures. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and high cash reserves mitigate financial risk. However, the negative operating cash flow of ¥49.39 million raises concerns about long-term sustainability without revenue growth acceleration. Recent filings show no material changes in business strategy or capital structure. The company continues to focus on biorefinery technology development, with no significant new partnerships or product launches disclosed in the last quarter.
Business. Green Earth Institute Co Ltd develops and commercializes green chemicals using biorefinery technology, focusing on research and development and license and product sales business models.
Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 92% confidence.
- Strong liquidity position with cash reserves covering 69% of total assets
- Conservative capital structure with low debt-to-equity ratio of 0.07
- Below-industry median profitability metrics require operational improvement
- Revenue concentration in domestic market and two business models increases risk
- Negative operating income persists despite positive net income
- Free cash flow insufficient to cover capital expenditures
- --
- ## RATIONALES
- No immediate filing-based liquidity or dilution flags were detected.